TNDM
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSTandem Diabetes Care, Inc. - Common Stock (TNDM) [ST]
www.tandemdiabetes.com ↗▼ 2.55%
prev close
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
Congressional Trades
3
All tracked trades
Members Trading
2
Unique members
Net Activity
-1
1 buys · 2 sells
Members Who Traded This Stock
3 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2025-09-22 | TNDMTandem Diabetes Care, Inc. - Common Stock | Buy | $1,001 - $15,000 | 169d ago | — | |
| 2025-03-19 | TNDMTandem Diabetes Care, Inc. - Common Stock | Sell | $1,001 - $15,000 | 357d ago | — | |
| 2023-07-12 | TNDMTandem Diabetes Care, Inc. - Common Stock | Sell | $1,001 - $15,000 | 963d ago | — |
2025-09-22
Josh Gottheimer
TNDM
Amount
$1,001 - $15,000
Filed
169d ago
2025-03-19
Josh Gottheimer
TNDM
Amount
$1,001 - $15,000
Filed
357d ago
2023-07-12
Daniel Goldman
TNDM
Amount
$1,001 - $15,000
Filed
963d ago
Recent News
Powered by Polygon.io
Tandem Diabetes Care, Inc. Investigated by the Portnoy Law Firm
[Latest] Global Intravenous Infusion Pump Market Size/Share Worth USD 14.02 Billion by 2035 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Tandem Diabetes Shares Rise 33% On Earnings Beat, Margin Expansion, Growth Outlook
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Trade Timeline
Congressional activity, newest first
Josh Gottheimer
2025-09-22 · Purchase
$1,001 - $15,000
Josh Gottheimer
2025-03-19 · Sale
$1,001 - $15,000
Daniel Goldman
2023-07-12 · Sale
$1,001 - $15,000